| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| AKRO | Akero Therapeutics, Inc. | Director | $422K | Jun 3, 2025 | ||
| FATE | FATE THERAPEUTICS INC | Director | $146K | May 29, 2025 | ||
| XLO | Xilio Therapeutics, Inc. | Director | Jun 11, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|